Tol1, a Fission Yeast Phosphomonoesterase, Is an In Vivo Target of Lithium, and Its Deletion Leads to Sulfite Auxotrophy
Lithium is the drug of choice for the treatment of bipolar affective disorder. The identification of an in vivo target of lithium in fission yeast as a model organism may help in the understanding of lithium therapy. For this purpose, we have isolated genes whose overexpression improved cell growth...
保存先:
| 出版年: | J Bacteriol |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
2000
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC94529/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10850973/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jb.182.13.3619-3625.2000 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
